Home | All trials

[RDF data]
Trial NCT00000348

Resource URI: http://static.linkedct.org/resource/trials/NCT00000348
PropertyValue
linkedct:brief_title Infusion Laboratory: Protocol 4 (Dihydrexidine) - 13
linkedct:condition <http://static.linkedct.org/resource/condition/2992>
linkedct:criteria Inclusion Criteria: M/F, ages 21-50. Meet DSM-IV criteria for cocaine dependence. Agree to conditions of the study and sign informed consent. Exclusion Criteria: Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nuring women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics. Acute hepatitis. Other medical condtions that deem participation to be unsafe.
linkedct:download_date Information obtained from ClinicalTrials.gov on December 30, 2009
linkedct:eligibility_gender Both
linkedct:eligibility_healthy_volunteers No
linkedct:eligibility_maximum_age 50 Years
linkedct:eligibility_minimum_age 21 Years
linkedct:enrollment 0 (xsd:int)
linkedct:firstreceived_date September 20, 1999
linkedct:id NCT00000348
rdfs:label Trial NCT00000348
linkedct:lastchanged_date August 16, 2005
linkedct:lead_sponsor_agency National Institute on Drug Abuse (NIDA)
linkedct:location <http://static.linkedct.org/resource/location/209856>
linkedct:nct_id NCT00000348
linkedct:number_of_arms 0 (xsd:int)
linkedct:number_of_groups 0 (xsd:int)
linkedct:official_title Infusion Laboratory: Protocol 4 (Dihydrexidine)
linkedct:org_study_id NIDA-3-0010-13
linkedct:overall_official <http://static.linkedct.org/resource/overall_official/60742>
linkedct:overall_status Active, not recruiting
linkedct:oversight <http://static.linkedct.org/resource/oversight/2918>
foaf:page <http://clinicaltrials.gov/show/NCT00000348>
linkedct:phase Phase 1
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/10066>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/16399>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/25534>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/4409>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/4700>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/6361>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/6373>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/8466>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/8470>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/9214>
linkedct:secondary_id Y01-3-0010-13
linkedct:source National Institute on Drug Abuse (NIDA)
linkedct:study_design Treatment, Open Label
linkedct:study_type Interventional
linkedct:summary The purpose of this study is to evaluate safety issues pertaining to dihydrexidine (DHX), to cocaine, and to its interaction, and to determine how pretreatment with DHX modifies the subjective as well as physiological effects of cocaine infusion.
rdf:type linkedct:trials
linkedct:verification_date December 2002